サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：セルソーティングの世界市場-2023年～2030年
市場調査レポート
商品コード
1297797

セルソーティングの世界市場-2023年～2030年

Global Cell Sorting Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
セルソーティングの世界市場-2023年～2030年
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

セルソーティングの世界市場は、2022年に2億3,650万米ドルに達し、2030年には3億8,980万米ドルまで成長すると予測されています。セルソーティングの世界市場は、予測期間2023-2030年にCAGR 6.6%を示すと予測されています。

セルソーティングは、研究、臨床診断、治療において数多くの用途があります。幹細胞や循環腫瘍細胞など、希少な細胞群を分離し、さらなる分析を可能にします。さらに、細胞ベースの医薬品の開発や免疫細胞集団の研究のような治療用途のために、特定の細胞タイプを精製することが容易になります。

しかし、装置の高価格、厳しい規制、熟練した人材の不足、新興諸国におけるセルソーティング技術に対する認識不足などが、セルソーティング市場の成長を阻害する要因となっています。

市場力学

慢性疾患負担の増加が予測期間中の世界セルソーティング市場の成長を後押しする

米国の成人の60％近くが少なくとも1つの慢性疾患に苦しんでいます。米国における主な死因は、糖尿病、がん、心血管疾患などの慢性疾患です。心臓病、がん、脳卒中、慢性閉塞性肺疾患、糖尿病は全死亡原因の3分の2以上を占めています。

CDCによれば、全米の年間医療費3兆8,000億米ドルの90％は、慢性疾患や精神衛生上の問題を抱える人々に起因しています。Partnership to Fight Chronic Diseaseの最近の報告書によると、2030年までに米国で最も流行している7つの慢性疾患の治療費は年間2兆米ドル、1人当たり8,600ドルになります。同報告書によれば、有害な行動を減らすことで、年間110万人の死亡を防ぐことが可能です。

成長するバイオ医薬品産業が予測期間中の世界セルソーティング市場の成長を後押しする

アメリカ最大の産業の一つはバイオ医薬品であり、年間数十億米ドルの価値があり、アメリカ経済とその製品を使用する患者にとって極めて重要です。このビジネスは、CDMOバイオロジクス企業の出現により、以前よりも迅速に医薬品を生み出すようになり、驚異的な拡大を経験しています。

この産業の拡大は、世界人口の拡大にも起因しています。世界人口からの需要は、バイオ医薬品ビジネスへの圧力を高めているが、同時に、より多くの投資を呼び込み、収益性を高め、拡大することを可能にしています。

個別化医療の拡大が世界セルソーティング市場の成長機会をもたらす

個別化医療では、診断、投薬、予防に対する「一人一人に合った」アプローチを変えることが可能です。患者固有の特徴に基づく標的治療が個別化医療の目標です。カスタマイズされた治療法のために特定の細胞タイプを特定し分離することは、セルソーティング技術に大きく依存しています。個別化医療が成長するにつれて、セルソーティング技術の需要は高まると予想されます。

COVID-19影響分析

COVID-19パンデミックはセルソーティング市場に好影響を与えました。免疫反応の変動性や様々な細胞タイプに対するCOVID-19の影響は、セルソーティングを含むシングルセル分析技術を用いて広く研究されています。パンデミックは、個々の細胞の特徴や反応を理解する必要性を強調することによって、単一細胞分析技術を強化し、セルソーティング技術に対する需要を増加させました。

ロシア・ウクライナ紛争分析

ロシアとウクライナの戦争がセルソーティング市場に与える影響は複雑で多面的です。紛争とその余波によって、影響を受けた地域のヘルスケア・インフラ建設のための資源、注目、資金が流用される可能性があります。このことは、セルソーティングのような最先端技術がヘルスケアや研究においてどのように採用され、使用されるかに影響を与えるかもしれないです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患検査の増加
    • 抑制要因
      • 高いコストとサービス
    • 機会
      • 技術の進歩
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争分析

第8章 人工知能分析

第9章 テクノロジー別

  • 蛍光活性化セルソーティング（FACS）
  • 磁気活性化セルソーティング（MACS）
  • マイクロ電気機械システム（MEMS）マイクロ流体工学
  • 密度勾配遠心法
  • 免疫密度細胞分離
  • 沈降
  • その他

第10章 製品・サービス別

  • セルソーター
  • セルソーティング試薬・消耗品
  • セルソーティングサービス

第11章 用途別

  • 臨床用途
  • 研究用途
    • 免疫学およびがん研究
    • 幹細胞研究
    • 創薬研究
    • その他の研究用途

第12章 エンドユーザー別

  • 研究機関
  • 製薬・バイオテクノロジー企業
  • 病院・臨床検査機関
  • 医学部および学術機関

第13章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第14章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な発展と戦略

第15章 企業プロファイル

  • Bio-Rad Laboratories, Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Sony Biotechnology Inc.
  • BD
  • Merck KGaA
  • Danaher Corporation
  • Miltenyi Biotec GmbH
  • Affymetrix, Inc
  • Sysmex Partec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Thermo Fisher Scientific

第16章 付録

目次
Product Code: BT1895

Market Overview

The Global Cell Sorting Market reached US$ 236.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 389.8 million by 2030. The Global Cell Sorting Market is expected to exhibit a CAGR of 6.6% during the forecast period 2023-2030.

Cell sorting has numerous applications in research, clinical diagnostics, and therapeutics. It makes it possible to separate rare cell groups, including stem cells or circulating tumor cells, for further analysis. Additionally, it makes it easier to purify particular cell types for therapeutic uses like developing cell-based medicines or researching immune cell populations.

However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.

Market Dynamics

The Rising Chronic Disease Burden is Boosting the Global Cell Sorting Market Growth During the Forecast Period

Nearly 60% of American adults suffer from at least one chronic illness. The major causes of death in the US include chronic diseases like diabetes, cancer, and cardiovascular disease. Heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes account for over two-thirds of all fatalities.

According to the CDC, 90% of the nation's $3.8 trillion in annual healthcare costs are attributable to persons with chronic illnesses and mental health issues. According to a recent report by the Partnership to Fight Chronic Disease, by 2030, the expense of treating the seven most prevalent chronic diseases in the United States will total $2 trillion annually or $8,600 per person. According to the same report, reducing harmful behaviors might prevent 1,100,000 deaths annually.

The Growing Biopharmaceutical Industry is Boosting the Global Cell Sorting Market Growth During the Forecast Period

One of the largest industries in America is biopharma, which is worth billions of dollars annually and is crucial to the American economy and the patients who use their products. This business is experiencing tremendous expansion due to the emergence of CDMO Biologics companies, which are generating pharmaceuticals more quickly than before.

The expansion of this industry is also attributed to an expanding world population. The demand from the world's population has increased pressure on the biopharma business, but it has also allowed it to attract more investment, increase profitability, and expand.

The Expansion of Personalized Medicine Provides the Global Cell Sorting Market Growth Opportunities

With personalized medicine, it's possible to transform a "one size fits all" approach to diagnosis, medication, and prevention into an individualized one. Targeted treatments based on unique patient traits are the goal of personalized medicine. Identifying and isolating particular cell types for customized therapeutics depend heavily on cell sorting technology. The demand for cell sorting technology is anticipated to rise as personalized medicine grows.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a positive impact on the cell sorting market. The variability of the immune response and the effects of COVID-19 on various cell types have been extensively studied using single-cell analytic techniques, including cell sorting. The pandemic has enhanced single-cell analysis techniques and increased demand for cell sorting technology by highlighting the need to comprehend individual cells' traits and reactions.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the cell sorting market is complex and multifaceted. Resources, attention, and finance for the construction of healthcare infrastructure in the impacted areas may be diverted by the conflict and its aftermath. This might affect how cutting-edge technologies, like cell sorting, are adopted and used in healthcare and research contexts.

Segment Analysis

The Global Cell Sorting Market is segmented based on technology, product and services, application, End-user, and region.

The Fluorescence-Activated Cell Sorting (FACS) Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The fluorescence-activated cell sorting (FACS) segment accounted for the highest market stake, accounting for approximately 43.6% of the cell sorting market in 2022. The flow cytometry technique, fluorescence-activated cell sorting (FACS), is specialized. Using the unique light scattering and fluorescence properties of each cell, it offers a way for dividing a heterogeneous mixture of living cells into two or more containers, one cell at a time.

It is a practical scientific tool since it allows for the quick, accurate, and quantitative recording of fluorescence signals from individual cells as well as the physical segregation of cells of specific interest.

Geographical Analysis

Increasing Collaborations And Product Launches by the Key Players, and Increasing FDA Approvals, Dominate the North American Region

North America is expected to dominate the cell sorting market, accounting for around 39.6%. The market player applies strategies such as product launches and collaboration to expand their business.

For instance, in January 2023, Thermo Fisher Scientific, the leader in serving science, launched the Bigfoot Spectral Cell Sorter in India. The groundbreaking cell sorting system combines spectral sorting and analysis with traditional sorting to produce quick, simple-to-use cell sorting.

Competitive Landscape

The major global players in the market include: Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the Global Cell Sorting Market segmentation based on the technology, product and services, application, End-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cell sorting market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Cell Sorting Market Report Would Provide Approximately 69 Tables, 70 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product and Services
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of chronic disease testing
    • 4.1.2. Restraints
      • 4.1.2.1. High costs and services
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Fluorescence-activated cell sorting (FACS)*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Magnetic-activated cell sorting (MACS)
  • 9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
  • 9.5. Density Gradient Centrifugation
  • 9.6. Immunodensity Cell Separation
  • 9.7. Sedimentation
  • 9.8. Others

10. By Product and Services

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 10.1.2. Market Attractiveness Index, By Product and Services
  • 10.2. Cell Sorters*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cell Sorting Reagents & Consumables
  • 10.4. Cell Sorting Services

11. By Application

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. Clinical Applications*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Research Applications
    • 11.3.1. Immunology & Cancer Research
    • 11.3.2. Stem Cell Research
    • 11.3.3. Drug Discovery
    • 11.3.4. Other Research Applications

12. By End user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 12.1.2. Market Attractiveness Index, By End user
  • 12.2. Research Institutes*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Pharmaceutical & Biotechnology Companies
  • 12.4. Hospitals and Clinical Testing Laboratories
  • 12.5. Medical Schools and Academic Institutions

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Bio-Rad Laboratories, Inc.*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. Sony Biotechnology Inc.
  • 15.3. BD
  • 15.4. Merck KGaA
  • 15.5. Danaher Corporation
  • 15.6. Miltenyi Biotec GmbH
  • 15.7. Affymetrix, Inc
  • 15.8. Sysmex Partec GmbH
  • 15.9. On-Chip Biotechnologies Co., Ltd.
  • 15.10. Thermo Fisher Scientific

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us